Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (2) , 408-414
- https://doi.org/10.1194/jlr.m200313-jlr200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Apolipoprotein E2 (Lys146→Gln) Causes Hypertriglyceridemia due to an Apolipoprotein E Variant–Specific Inhibition of Lipolysis of Very Low Density Lipoproteins–TriglyceridesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Apolipoprotein E Participates in the Regulation of Very Low Density Lipoprotein-Triglyceride Secretion by the LiverJournal of Biological Chemistry, 1999
- Apolipoprotein E2 Reduces the Low Density Lipoprotein Level in Transgenic Mice by Impairing Lipoprotein Lipase-mediated Lipolysis of Triglyceride-rich LipoproteinsPublished by Elsevier ,1998
- Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent mannerBiochemical Journal, 1997
- Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.Journal of Clinical Investigation, 1997
- Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.Journal of Clinical Investigation, 1997
- Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions andPublished by Elsevier ,1996
- Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and TreatmentAnnals of Internal Medicine, 1983
- Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2Journal of Lipid Research, 1982
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981